Workflow
新华医疗: 新华医疗第十一届董事会第二十次会议决议公告

Meeting Overview - The 20th meeting of the 11th Board of Directors of Shandong Xinhua Medical Instruments Co., Ltd. was held on August 27, 2025, with all 11 directors present, complying with legal and regulatory requirements [1]. Financial Reporting - The Board approved the 2025 Half-Year Report, confirming that the report accurately reflects the company's actual situation, with a unanimous vote of 11 in favor [2]. - The Board also approved a special report on the storage and actual use of raised funds for the first half of 2025, stating compliance with relevant regulations and confirming no misuse of funds [2]. ESG Reporting - The Board approved the 2024 Environmental, Social, and Governance (ESG) report, affirming that it meets legal and regulatory standards and accurately reflects the company's situation, with a unanimous vote of 11 in favor [3]. Governance Improvements - The Board approved the establishment and revision of certain governance systems to enhance company quality in line with the latest regulatory requirements, with a unanimous vote of 11 in favor [3].